Form 8-K · Current report
Skyworks Solutions 8-K, filed Aug 3, 2026
- Filed
- CIK
- 0000004127
- Accession no.
- 0001104659-26-089397
Summary
The U.S. Hart-Scott-Rodino waiting period for Skyworks Solutions' proposed merger with Qorvo has expired, and the FTC allowed its timing agreement to expire without further action, leaving China's State Administration for Market Regulation and South Korea's Korea Fair Trade Commission as the only open jurisdictions. Skyworks said it hopes to close the transaction within the calendar year and is preparing to close as early as within its fiscal year, with no assurances.
Key points
- Skyworks and Qorvo entered a merger agreement on October 27, 2025, under which Qorvo would become a wholly owned Skyworks subsidiary through a two-step merger.
- The HSR waiting period has expired, and the FTC allowed its timing agreement to expire on August 1, 2026, without further action.
- China's State Administration for Market Regulation and the Korea Fair Trade Commission remain the only open jurisdictions for antitrust approval.
- Foreign investment approvals have been cleared, and Skyworks hopes to close within the calendar year, with no assurances.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
From the filing
Item 8.01. Other Events. As previously announced, on October 27, 2025, Skyworks Solutions, Inc. (“Skyworks”) entered into an Agreement and Plan of Merger (the “Merger Agreement”), with Qorvo, Inc., a Delaware corporation (“Qorvo”), Comet Acquisition Corp., a Delaware corporation and a wholly owned subsidiary of Skyworks (“Merger Sub I”), and Comet Acquisition II, LLC, a Delaware limited liability company and a wholly owned subsidiary of Skyworks (“Merger Sub II”). …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.